Press Release

Global Next Generation Sequencing (NGS) Market is Expected to Grow at a CAGR of 21% between 2020 and 2025.

According to a new report by EMR titled, 'Global Next Generation Sequencing (NGS) Market Report and Forecast 2020-2025', the global next generation sequencing (NGS) market size was valued at USD 8 billion in 2019. The market is further expected to grow at a CAGR of 21% in the forecast period of 2020-2025 to reach USD 24 billion by 2025.

The global next generation sequencing (NGS) market has North America as a significant market owing to its largest market share. The market is driven by the technological advancements in NGS, boost in partnerships and collaborations, and rise in the application of next generation sequencing. Huge demand from the end-user industries, such as academic and clinical research centres, hospitals and clinics, and pharmaceutical and biotechnology companies, among others, are providing impetus to the market growth of the next generation sequencing (NGS). Several applications of NGS such as oncology studies, biomarker studies, agricultural and animal research, and personalised medicine, among others, are witnessing a boost in their demand, thus, propelling the next generation sequencing (NGS) market growth.

Illumina, Inc. (NASDAQ: ILMN) and F. Hoffmann-La Roche Ltd. (SWX: ROG) are the major key players in the next generation sequencing (NGS) market. In October 2019, Illumina, Inc., along with QIAGEN N.V. (NYSE: QGEN), announced a 15-year long partnership with the purpose of increasing the availability and the use of NGS based IVD kits such as companion diagnostics for patient management.

Market Analysis by Component, Technology, Application, and Region:

  • The next generation sequencing (NGS) market, on the basis of component, is bifurcated into NGS platforms and NGS services.
  • On the basis of technology, the market is divided into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, and nanopore sequencing, among others.
  • The market is categorised on the basis of application into diagnostics, drug discovery, and agricultural and animal research, among others.
  • Regionally, the market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of The Report:

  • The global next generation sequencing (NGS) market is driven by the innovations in systems of the next-generation sequencing.
  • The market is further aided by the technological advancements in the field, providing players with a quick competitive edge, as a result, making sure that the product development and research have consistent focus.
  • The declining costs of next generation sequencing (NGS) platforms are providing impetus to the market growth of next generation sequencing.
  • Enhancing regulatory and reimbursement scenario for NGS based diagnostic tests is accelerating the market growth.

Key Offerings of the Report:

  • The EMR report gives an overview of the global next generation sequencing (NGS) market for the periods (2015-2019) and (2020-2025).
  • The report also offers the historical (2015-2019) and forecast (2020-2025) market trends for the component, technology, application, and regional markets of the global next generation sequencing (NGS) market.
  • It assesses the market based on the SWOT and Porter’s Five Forces model as well.

Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., PierianDx, Genomatix GmbH, Eurofins GATC Biotech GmbH, Oxford Nanopore Technologies, Macrogen, Inc., Thermo Fisher Scientific, Inc., DNASTAR, Inc., and Biomatters Ltd., among others, are the key players in the global next generation sequencing (NGS) market. The EMR report looks into the capacity, market share, and latest developments of these major players like plant turnarounds, mergers and acquisitions, and capacity expansions.

About Us:

EMR is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At EMR, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Contact Us:

Expert Market Research
Website:
www.expertmarketresearch.com
Email: sales@expertmarketresearch.com
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790

Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER